Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Keynote | 2025's Orthopaedic Leaders

Wednesday, June 14
7:30 am - 9:00 am
(Breakfast served at 7:30 am, Keynote at 8:00 am)
Room 51 




Urbanowicz Consulting



Scott Bruder,
M.D., Ph.D.

Bruder Consulting and Venture Group


Eric Lohrer

Loreda Holding


Kyle Rose

Principal, Medical Technologies
Canaccord Genuity




Which orthopaedic companies and technologies will stand at the forefront of innovation in 2025? The Keynote Panel sets out to answer this question, and in so doing, will discuss current and future market forces and the ways that companies should respond, finishing with predictions for 2025.

The panel comprises executives with diverse experience working at the industry’s largest orthopaedic companies down to its startups. These are the people tracking the strategic activity of public companies and investing, negotiating and completing due diligence on innovative, industry-leading, profitable companies globally.


Attendee Takeaways

  1. Business-critical market forces that require your attention
  2. Examples of orthopaedic strategies/responses
  3. Outlook on winning companies and technologies



Don Urbanowicz is Principal of Urbanowicz Consulting, an advisory firm with a musculoskeletal focus seeking to enable clients to achieve strategic and transaction-related goals by capitalizing on market opportunities. Mr. Urbanowicz has a 30-year track record in the healthcare industry, with a deal-making focus over the past ten years.  He has held prior senior management/leadership positions at Stryker, Smith & Nephew, Sofamor Danek and Aircast. He has successfully developed and implemented strategic planning and business development transaction life cycle processes. He has also successfully concluded numerous pre-revenue and bolt-on transactions, many of which were outside the U.S.


Scott Bruder, M.D., Ph.D. is an insightful and energetic healthcare leader with over 20 years of experience in bridging basic science, clinical medicine and industrial development expertise to deliver innovative, commercially successful products that improve patients’ lives around the world. As a seasoned Senior Executive, University Professor and FDA Advisory Committee Member, he provides a unique bench-to-bedside perspective on unmet needs, development strategy and the path to commercialization.  Dr. Bruder previously served in executive roles at Johnson & Johnson, Stryker, BD and Anika Therapeutics. Among his current roles, he serves as Principal of Bruder Consulting and Venture Group, Chairman of the Board of Directors at Amendia and Senior Advisor, Orthopaedics and Regenerative Medicine at Wombat Capital.

Eric Lohrer is an experienced and well-rounded manager with multi-continent (Asia-Pacific, EMEA, U.S.) multi-function (sales, marketing, R&D, business development and finance) experience in orthopaedics. He currently invests in healthcare and technology companies on behalf of Synthes founder, Hansjörg Wyss, globally. Among his current roles, he serves on the boards of Lima Corporate, Amazentis and 41medical, where he also serves as CEO, and he is a partner at Loreda Holding. Mr. Lohrer previously held several management roles at Synthes and Johnson & Johnson’s DePuy Synthes, and worked for Credit Suisse First Boston in New York.

Kyle Rose has been a member of Canaccord Genuity’s medical technology research team since 2010 and in 2016 assumed senior analyst responsibilities covering the orthopaedics, diabetes, aesthetics and ENT sectors. Prior to joining Canaccord Genuity, Mr. Rose worked as an associate product manager for Biomet Microfixation. The companies Mr. Rose covers includes: ConforMIS, Globus Medical, NuVasive, Stryker and Zimmer Biomet. He holds an MBA from the Kellogg School of Management at Northwestern University, as well as a bachelor's degree from the University of Michigan.

Helpful links: Orthopaedic Industry Surpasses $46 Billion  | Handling Disruption: The Need for Proprietary Business Models